ArticleProceedings of the National Academy of Sciences of the United States of America2023

Proteasome inhibitor bortezomib stabilizes and activates p53 in hematopoietic stem/progenitors and double-negative T cells in vivo.

Yuezhen Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.